|
National Stock Number(NSN): 6505-00-582-5291 (6505005825291, 005825291)
| NIIN: |
00-582-5291 |
Item Name: |
Item Name not available. |
INC: |
00000
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1963 |
CRIT: |
N |
IIG: |
00000 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-01-2003 |
PMIC: |
A |
FIIG: |
|
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
|
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
ASTHMANEFRIN |
59263
|
NORCLIFF THAYER INC |
H |
5 |
9 |
4 |
KX |
|
B |
|
|
|
|
|
DEY-DOSE |
62947
|
MYLAN SPECIALTY LP |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00235-1201-05 |
58827
|
FISONS CORP PRESCRIPTION DIV |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00585-0201-05 |
58827
|
FISONS CORP PRESCRIPTION DIV |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
NDC00585-1201-05 |
58827
|
FISONS CORP PRESCRIPTION DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00766-5010-01 |
59263
|
NORCLIFF THAYER INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC49502-0054-14 |
62947
|
MYLAN SPECIALTY LP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
VAPONEFRIN |
58827
|
FISONS CORP PRESCRIPTION DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
M |
U |
1 |
A |
$29.76 |
BT |
|
C2201X- |
Oct-01-2003 |
H |
| DF |
JDC |
Y |
|
M |
U |
1 |
F |
$29.76 |
BT |
|
------- |
Oct-01-2003 |
H |
| DN |
JDC |
Y |
|
M |
U |
1 |
N |
$29.76 |
BT |
|
9L----- |
Oct-01-2003 |
H |
| DS |
JDC |
Y |
|
M |
U |
1 |
D |
$29.76 |
BT |
|
------- |
Oct-01-2003 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 30ML |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 30ML |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 30ML |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 30ML |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 TO 2.250 PERCENTAGE EPINEPHRINE EQUIVALENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
30.000 MILLILITERS |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
RACEPINEPHRINE INHALATION SOLUTION USP 30ML BT |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
1.10 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
144 |
| PKQT |
INTERMEDIATE PACKAGE QUANTITY |
12 |
| SUCB |
UNIT OF ISSUE CUBE |
0.008 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.18 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
|